TrialPath
← Back to searchRecruiting

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing

NCT06785441 · M.D. Anderson Cancer Center
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
Primary Objective: The overall goal of this protocol is to test initial efficacy of three versions of an educational tool for use by patients and health-care providers to help men with localized prostate cancer make informed decisions about discontinuation of active surveillance. A pre-post design was selected to provide initial efficacy data of the different versions of the shared decision-making intervention. Thereby, providing preliminary data in preparation for a follow-up comparative study.
Eligibility criteria
Inclusion Criteria: Patients: 1. Males aged 65 or older 2. Diagnosis of localized prostate cancer 3. Have not received curative intent treatment for their prostate cancer 4. Fluent in English Care partners/caregivers: 1. Aged 18 or older 2. Fluent in English 3. Involved with the care of an eligible patient (i.e. partner, close friend, family member, companion) Exclusion Criteria: Patients 1\. Currently receiving treatment for another cancer (primary or recurrence) Care partners/caregivers 1\. None
Study design
Enrollment target: 180 participants
Age groups: older_adult
Timeline
Starts: 2023-05-25
Estimated completion: 2030-02-02
Last updated: 2025-02-04
Primary outcomes
  • Preparation for Decision Making Scale (Through study completion and average of 1 year)
Sponsor
M.D. Anderson Cancer Center · other
With: American Cancer Society, Inc.
Contacts & investigators
ContactLisa Lowenstein, MD · contact · deescalatepca@mdanderson.org · 713-563-0020
InvestigatorLisa Lowenstein, MD · principal_investigator, M.D. Anderson Cancer Center
All locations (1)
M.D. Anderson Cancer CenterRecruiting
Houston, Texas, United States
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing · TrialPath